Author(s): Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC
Abstract Share this page
Abstract A dopamine receptor has been characterized which differs in its pharmacology and signalling system from the D1 or D2 receptor and represents both an autoreceptor and a postsynaptic receptor. The D3 receptor is localized to limbic areas of the brain, which are associated with cognitive, emotional and endocrine functions. It seems to mediate some of the effects of antipsychotic drugs and drugs used against Parkinson's disease, that were previously thought to interact only with D2 receptors.
This article was published in Nature
and referenced in Journal of Molecular Biomarkers & Diagnosis